# Desk log EA-FREEZE-20260823

**Status:** First-party illustrative assignment composite; not customer, production, randomized-trial, benchmark, or independently audited data  
**Run date:** 2026-08-23  
**Evidence checked:** 2026-08-31  
**Operator:** InfiniSynapse Data Team  
**Attestor:** William Zhu, InfiniSynapse cofounder ([GitHub @allwefantasy](https://github.com/allwefantasy))

The operator inspected an illustrative 28-day pack: 64,200 users split 50.4%/49.6%, a 1.1-point checkout delta, and a 0.3-point refund delta. The SRM conclusion is withheld because the expected allocation and test output are unavailable. Shipping remained held for the late adverse refund join.

The [CSV](https://infinisynapse.com/blog-media/experiment-analysis/downloads/assignment-summary-EA-FREEZE-20260823.csv) exposes five aggregates and two held items. The [verification script](https://infinisynapse.com/blog-media/experiment-analysis/downloads/verify-EA-FREEZE-20260823.py) checks displayed output only. Assignment/outcome rows, intervals, variances, SQL, stopping rule, and SRM test are unavailable.

External context: [ASA p-value statement](https://www.amstat.org/asa/files/pdfs/p-valuestatement.pdf), [NIST/SEMATECH e-Handbook](https://www.itl.nist.gov/div898/handbook/), and [FDA Adaptive Designs guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/adaptive-designs-clinical-trials-drugs-and-biologics-guidance-industry) (retrieved 2026-08-31). These publishers did not review this run.